Barlow Robbins Solicitors, Ecovis’ UK legal partner, recruits life sciences partner

The UK has one of the largest life sciences markets in the world and the sector commands an important position within the UK economy.

Barlow Robbins has recruited Tim Matthews as an additional partner in its Corporate and Commercial group. Tim has wide experience in the life sciences sector with over 25 years’ experience acting for UK-listed international and private companies primarily from the life science and technology sectors.

Life sciences sector clients require specialist advice on a wide range of legal areas such as creating commercial agreements for product manufacturing and research, or for advice on navigating the many regulatory issues in this sector. The expertise also extends to brand protection with strategic advice on copyright laws and intellectual property rights.

Due to the sheer size of this industry the needs of our client base are going to become more international. We are perfectly placed to meet these needs and look forward to supporting our clients as they adapt to a changing environment, in co-operation with our other colleagues throughout the global Ecovis network.

Barlow Robbins life sciences work highlights

• Tim Matthews previously advised Midatech Pharma PLC, an international pharmaceutical company, on its acquisition of DARA BioSciences, a NASDAQ-listed oncology supportive care pharmaceutical company based in North Carolina.
• Supporting family owned Veriton Pharma, formerly Special Products, on their product portfolio, export network and product licensing. Mark Lucas comments, “Supporting an SME that has ambitious plans to grow globally is exciting, and perfectly aligned to our business. They have a good appetite for risk and genuinely appreciate our expertise and advice. It has been great to see the evolution of their balanced portfolio of projects in an equally balanced portfolio of territories, growing into Dubai to service the Middle East territories; and in Melbourne, Australia – all with the plan of mitigating risks after BREXIT!”

Author
Tim Matthews, Partner in the Corporate and Commercial Department, Barlow Robbins LLP, Guildford, Surrey, UK
tim.matthews@BarlowRobbins.com